Pharmacokinetics (PK) of Antistaphylococcal Antibiotics in Infants (NICHD-2012-02-Staph Trio) (Staph)
Pharmacokinetics of Antistaphylococcal Antibiotics in Infants
Sponsor: Phillip Brian Smith
This PHASE1 trial investigates Systemic Infection and is currently completed. Phillip Brian Smith leads this study, which shows 11 recorded versions since 2013 — indicating substantial longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1
-
Aug 2023 — Jul 2024 [monthly]
Completed PHASE1
-
Jul 2023 — Aug 2023 [monthly]
Completed PHASE1
-
Jan 2021 — Jul 2023 [monthly]
Completed PHASE1
▶ Show 6 earlier versions
-
Feb 2020 — Jan 2021 [monthly]
Completed PHASE1
-
Jul 2019 — Feb 2020 [monthly]
Completed PHASE1
-
Jan 2019 — Jul 2019 [monthly]
Completed PHASE1
-
Jun 2018 — Jan 2019 [monthly]
Completed PHASE1
-
Feb 2017 — Jun 2018 [monthly]
Completed PHASE1
-
Jan 2017 — Feb 2017 [monthly]
Completed PHASE1
First recorded
Jan 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Phillip Brian Smith
For direct contact, visit the study record on ClinicalTrials.gov .